McKinsey Biotech and Medtech Angel Investor Conference, with collaboration of MA2 and MassBio
We are delighted to inform you of the first McKinsey Biotech and Medtech Angel Investor conference, in collaboration with MA2 and MassBio, on the afternoon of Tuesday, November 14 at the McKinsey Boston office.
The purpose of this event is to convene angel investors and other stakeholders of early-stage innovation, such as leading university researchers, clinicians, and start-up CEOs, to discuss the next frontier in Biotech and Medtech innovation. The conference is an informal, private gathering. This forum will allow participants to debate and share ideas about the future of Biotech and Medtech, to hear from leaders from other parts of the Biotech and Medtech space, and to build deeper relationships across the early innovation community.
The agenda includes discussion and presentations on:
- Key trends shaping Biotech and Medtech
- The next frontier of innovation in Biotech and Medtech, with pitches by leaders of innovative academic labs and start-up CEOs on emerging ideas and early-stage technologies
- Perspectives on the start-up investment journey by later-stage stakeholders (e.g., Biopharma leaders, VC)
Please use the link below to pre-register for the conference. We will confirm invitations at a later date.